Nynne Nyboe Andersen, MD

Nynne Nyboe Andersen
PhD student
Statens Serum Institut
5 Artillerivej , 206/204
DK-2300 Copenhagen S
+45 3268 3268


Nynne Nyboe Andersen is as of 1st of June 2012 employed by the Department of Epidemiology Research with the primary objective to conduct a Ph.D thesis within the field of Gastroenterology. Nynne Nyboe Andersen is educated as a medical doctor in January 2011 from the University of Copenhagen.

Research area

Gatroenterology, epidemiological research.

Is presently conducting the PhD study 'Safety of Anti-Tumor Necrosis Factor - alpha Treatment - A nationwide Cohort Study'.

Selected publications

  • Andersen NN, Pasternak B, Basit S, Andersson M, Svanström H, Caspersen S, Munkholm P, Hviid A, Jess T Association between tumor necrosis factor-alpha antagonists and risk of cancer in patients with inflammatory bowel disease. JAMA.2014; 311, 2406-2413 PubMed
  • Andersen NN, Jess T Risk of cardiovascular disease in inflammatory bowel disease. World J Gastrointestinal Pathophysiology.2014; 5, 359-365
  • Andersen NN, Jess T Has the risk of colorectal cancer in inflammatory bowel disease decreased?. World J Gastroenterol.2013; 19, 7561-7568
  • Pedersen N, Elkjaer M, Duricova D, Burisch J, Dobrzanski C, Andersen NN, Jess T, Bendtsen F, Langholz E, Leotta S, Knudsen T, Thorsgaard N, Munkholm P eHealth: Individualization of infliximab treatment and disease course via self-initiated web-based solution in Crohn's disease. Aliment Pharmacol Ther.2012; 36, 840-849